This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related letters  • Similar articles in JAMA  Topic Collections  • Drug Therapy, Other  • Statistics and Research Methods  • Neurology  • Stroke  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: We very much agree with Dr Clegg's comment; our estimate of potential harm based on the use of different doses of aspirin was intended to be speculative. We included it in our review solely to highlight that the global implications for the routine use of different doses of aspirin may not be insignificant. The only way to know the true difference is through an adequately powered clinical trial comparing ~ 81 mg with ~ 325 mg of aspirin daily. We are not aware of any trial doing so in long-term cardiovascular disease prevention, although the ongoing Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS (CURRENT/OASIS 7) trials will compare this dose range of aspirin among 14 000 acute coronary syndrome patients for 30 days following a percutaneous coronary intervention.¹

We disagree with Dr Wong's conclusion that 160 mg of aspirin daily is more effective in the prevention of . . . [Full Text of this Article]

Charles L. Campbell, MD; Susan Smyth, MD, PhD; Steven R. Steinhubl, MD
steinhubl@uky.edu
University of Kentucky
Lexington

Gilles Montalescot, MD, PhD
Institut de Cardiologie—Centre Hospitalier
Universitaire Pitié-Salpêtrière
Paris, France

RELATED LETTERS

Aspirin Dose and Cardiovascular Disease Prevention
Andrew Clegg
JAMA. 2007;298(6):625.
EXTRACT | FULL TEXT  

Aspirin Dose and Cardiovascular Disease Prevention
George Kwok Chu Wong
JAMA. 2007;298(6):625.
EXTRACT | FULL TEXT